ECRI: More than half of disposable gowns tested don’t meet protection standards
Editor's Note A new analysis by ECRI shows that 52% of the disposable isolation gowns it tested failed to meet standard levels of protection, putting healthcare workers at risk of exposure to bloodborne or other pathogens as well as COVID-19. ECRI announced November 10 that it has issued a high-priority…
AI tool detects COVID-19 by listening to patients’ coughs
Editor's Note Researchers from the Massachusetts Institute of Technology, Cambridge, have developed an artificial intelligence (AI) tool that can detect COVID-19 by listening to patients’ coughs, regardless if they are symptomatic or not. To build the tool, the researchers solicited audio recordings of patients coughing and accompanying information about their…
FDA issues EUA for first test to detect neutralizing antibodies after COVID-19
Editor's Note The Food and Drug Administration (FDA) on November 6 issued an emergency use authorization (EUA) for the first serology test (GenScript USA Inc) to identify patients with neutralizing antibodies after a COVID-19 infection. Neutralizing antibodies have reduced the infection of cells in the laboratory, but their effects in…
Perioperative Nurse Week is November 8 to 14
Editor's Note Every year, AORN chooses a week to focus attention on the work of more than 160,000 nurses who advocate for surgical patients. This year the week is celebrated November 8 to 14. During the week, perioperative nurses are honored by colleagues and communities to highlight the ways nurses…
Pfizer, BioNTech COVID-19 vaccine more than 90% effective, EUA application could come next week
Editor's Note Pfizer and BioNTech announced November 9 that their COVID-19 vaccine is more than 90% effective 7 days after the second dose in preventing COVID-19 infection in participants without evidence of prior infection. This means that protection is achieved 28 days after initiation of the vaccination, which consists of…
Final report on Remdesivir study for treatment of COVID-19
Editor's Note The November 5 final report on data from this double-blind, randomized, placebo-controlled study of intravenous remdesivir in adults hospitalized with COVID-19 and lower respiratory tract infection shows that remdesivir was superior to placebo in shortening the time to recovery. A total of 1,062 patients were randomized to remdesivir…
CMS: How to prepare for COVID-19 vaccine
Editor's Note The Centers for Medicare and Medicaid Services (CMS) on November 5 released a set of toolkits and enrollment actions to take to administer the COVID-19 vaccine when it’s available. Many Medicare-enrolled providers don’t have to take any actions until the vaccine is available. Some Medicare-enrolled providers must also…
CDC: Birth, infant outcomes after COVID-19 in pregnancy
Editor's Note In this analysis of COVID-19 data from the Centers for Disease Control and Prevention, the proportion of preterm live births in women with COVID-19 infection during pregnancy was higher than that in the general population in 2019, suggesting that pregnant women with COVID-19 infection might be at risk…
FDA alerts providers on how to prevent false positive results with COVID-19 antigen tests
Editor's Note The Food and Drug Administration (FDA) on November 3 issued a letter alerting clinical laboratory staff and healthcare providers that false positive results can occur with antigen tests, including when users do not follow instructions for use of antigen tests for the rapid detection of COVID-19. Among the…
Hospital floors are hotspots for healthcare-associated pathogens
Editor's Note Healthcare-associated pathogens rapidly accumulate on the floors of patient rooms and can be transferred to patients’ socks, bedding, and high-touch surfaces, finds this study published November 2 as part of the proceedings from Decennial 2020: The Sixth International Conference on Healthcare-Associated Infections. Researchers from the Northeast Ohio VA…